Baird Medical Investment Holdings Inc. (BDMD)
Market Closed
10 Aug, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
1. 22
0
0%
$
51.49M Market Cap
- P/E Ratio
- Div Yield
67,928 Volume
- Eps
$ 1.22
Previous Close Investors:
Want to track BDMD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
BDMD closed today higher at $1.22, an increase of 0% from yesterday's close, completing a monthly increase of 18.4466% or $0.19. Over the past 12 months, BDMD stock lost -11.5942%.
BDMD is not paying dividends to its shareholders.
The last earnings report, released on Dec 05, 2025, missed the consensus estimates by -0.43%. On average, the company has fell short of earnings expectations by -0.43%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
Baird Medical Investment Holdings Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| NA Nizar Araji National Bank Of Canada /FI/ | 28,484 | $35,213.6 | $34,750.48 | -$463.12 | -1.32% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 4 | $4.6 | $4.4 | -$0.2 | -4.35% |
Baird Medical Investment Holdings Inc. (BDMD) FAQ
What is the stock price today?
The current price is $1.22.
On which exchange is it traded?
Baird Medical Investment Holdings Inc. is listed on NASDAQ (CM).
What is its stock symbol?
The ticker symbol is BDMD.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 51.49M.
Has Baird Medical Investment Holdings Inc. ever had a stock split?
No, there has never been a stock split.
Baird Medical Investment Holdings Inc. Profile
| Health Care Providers & Services Industry | Healthcare Sector | Haimei Wu CEO | NASDAQ (CM) Exchange | G0705H103 CUSIP |
| CN Country | 146 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Baird Medical Investment Holdings Limited is a prominent entity in the field of medical devices, focusing on the development and sales of microwave ablation technology for the treatment of tumors through a minimally invasive approach. Founded in 2012 and based in Guangzhou, China, the company has carved a niche in the Chinese medical market by offering innovative solutions for the treatment of both benign and malignant tumors. Its technology represents a significant advance in the realm of oncology, providing patients with safer, less invasive treatment options.
Products and Services
- Microwave Ablation Devices - Baird Medical's flagship products utilize microwave ablation technology, a cutting-edge technique for the treatment of tumors. These devices are designed for minimally invasive procedures, allowing for precise targeting and destruction of tumor cells without the need for traditional, more invasive surgical methods. Microwave ablation boasts shorter recovery times and fewer complications, making it a preferred choice for the treatment of:
- Thyroid Nodules - Employing microwave ablation for benign and potentially malignant thyroid nodules provides a non-surgical alternative, reducing the risks associated with thyroid surgery and preserving thyroid function.
- Liver Cancer - Microwave ablation devices offer a less invasive treatment option for liver cancer, capable of directly destroying cancer cells while sparing surrounding healthy tissue.
- Lung Cancer - These devices provide an innovative approach to treating lung cancer, particularly for patients who may not be suitable candidates for traditional surgery.
- Breast Lumps - A minimally invasive treatment for benign and malignant breast lumps, microwave ablation presents an effective alternative to surgical removal, offering cosmetic advantages and reduced recovery time.
Contact Information
Address: Room 202
Phone: 86 20 8218 5926
Website: https://www.bairdmed.com
